Galway, Ireland

Gabriel Brennan

USPTO Granted Patents = 2 

Average Co-Inventor Count = 1.8

ph-index = 1

Forward Citations = 28(Granted Patents)


Location History:

  • Ballybrit, IE (2016)
  • Galway, IE (2018)

Company Filing History:


Years Active: 2016-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Gabriel Brennan in Renal Neuromodulation

Introduction

Gabriel Brennan is an accomplished inventor based in Galway, Ireland. He has made significant contributions to the field of renal neuromodulation, focusing on innovative methods for treating hyperaldosteronism. With a total of 2 patents to his name, Brennan's work is paving the way for advancements in medical technology.

Latest Patents

Brennan's latest patents include groundbreaking technologies aimed at improving the treatment of hyperaldosteronism. One of his patents, titled "Renal neuromodulation methods and systems for treatment of hyperaldosteronism," discloses methods that inhibit sympathetic neural activity in renal nerves near a renal blood vessel. This technology aims to improve measurable physiological parameters related to hyperaldosteronism in patients. Additionally, it seeks to reduce central sympathetic drive, thereby providing a therapeutic approach to managing the condition. Another notable patent is "Endovascular nerve monitoring devices and associated systems and methods," which describes a nerve monitoring system designed to be positioned intravascularly at treatment sites. This system includes a bipolar stimulation electrode array and a bipolar recording electrode array, enhancing the capabilities of nerve monitoring during medical procedures.

Career Highlights

Brennan is currently associated with Medtronic Ardian Luxembourg S.a.r.l., where he continues to innovate in the medical technology sector. His work is characterized by a commitment to improving patient outcomes through advanced therapeutic techniques.

Collaborations

Throughout his career, Brennan has collaborated with notable professionals in the field, including Dwayne S. Yamasaki and Bryan L. Courtney. These collaborations have contributed to the development of his innovative patents and have enhanced the impact of his work in renal neuromodulation.

Conclusion

Gabriel Brennan's contributions to renal neuromodulation represent a significant advancement in the treatment of hyperaldosteronism. His innovative patents and ongoing work at Medtronic Ardian Luxembourg S.a.r.l. highlight his dedication to improving medical technology and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…